Business Standard

Friday, December 20, 2024 | 04:14 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Shareholder activism at Alembic Pharma: Issue unlikely to die in a hurry

Alembic's board rejected the request by Unifi Capital to appoint Murali Rajagopalachari as director

Shareholder activism at Alembic Pharma: Issue unlikely to die in a hurry
Premium

Sohini DasAneesh Phadnis Ahmedabad | Mumbai
Alembic’s board on Friday rejected the request by Unifi Capital to appoint Murali Rajagopalachari as a director for small shareholders but experts said it might write to the Securities and Exchange Board of India (Sebi) on the issue. 

Some experts said the group of small shareholders might move the National Company Law Tribunal (NCLT) as a last resort. 

Unifi Capital said it was studying its options in response to Alembic's decision to reject its proposal. 

Sarath Reddy, managing director, Unifi Capital, said, "We spent nearly a year in discussions with the company and offered specific suggestions with supporting rationale. They

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in